ASX listed biotech, PharmAust, has put a call out for canine volunteers to join its anti-cancer drug treatment trials in partnership with veterinary practices across Australia. The trials will study the effectiveness of Pharmaust’s anti-cancer drug in dogs suffering from B cell lymphoma – the most common canine cancer. Preliminary findings from phase I trials were very positive, with a notable reduction in tumours and prolonged lifespan.
04/11/2019 - 08:38
Pharmaust calls for K9 volunteers for cancer drug trials
By Matt Birney
04/11/2019 - 08:38
Related Data & Insights
-
-
Rank Company Revenue th PharmAust $842k 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
21 Jun 2024
PharmAust taps investors for $10m
31 May 2024
Shares rise following Thurn return
17 May 2024
Board Moves May 17, 2024
17 May 2024
PharmAust receives FDA approval
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX